Business Context and Reporting Period
Company: Bruker BioSciences Corporation
Filing Type: Form 8-K (Current Report)
Report Date: May 4, 2004
Reporting Period: Quarter ended March 31, 2004
Context: The company announced its results of operations for the quarter. Detailed financial data is contained in a press release attached as Exhibit 99.1, which is incorporated by reference.
Key Financial Metrics
The filing text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are referenced as being available in the attached press release (Exhibit 99.1) but are not present in the body of this Form 8-K.
Material Changes
The filing text does not provide specific details regarding material changes versus the prior comparable period. Investors must refer to the attached press release for comparative analysis.
Guidance, Outlook, and Risks
Management Commentary: The filing serves as a notification of the announcement of quarterly results. No specific guidance, outlook, or management commentary is included in the text of this report.
Risks and Contingencies: The filing includes a standard disclaimer stating that the information furnished shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section, nor incorporated by reference in Securities Act filings except as expressly set forth.
Important Facts for Investor Verification
- Verify the specific revenue and net income figures in the attached press release (Exhibit 99.1), as they are not listed in this summary document.
- Confirm the company's liquidity position and cash flow status from the full press release.
- Note that this 8-K is a notification of results rather than a detailed financial statement; the primary source of data is the referenced exhibit.
- Review the full text of Exhibit 99.1 for any forward-looking statements or risk factors not captured in this brief filing.